211 related articles for article (PubMed ID: 12469189)
1. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
Benelli R; Morini M; Brigati C; Noonan DM; Albini A
Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.
Benelli R; Morini M; Carrozzino F; Ferrari N; Minghelli S; Santi L; Cassatella M; Noonan DM; Albini A
FASEB J; 2002 Feb; 16(2):267-9. PubMed ID: 11772950
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.
Benelli R; Barbero A; Ferrini S; Scapini P; Cassatella M; Bussolino F; Tacchetti C; Noonan DM; Albini A
J Infect Dis; 2000 Dec; 182(6):1643-51. PubMed ID: 11069235
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
6. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
[TBL] [Abstract][Full Text] [Related]
7. Endothelial progenitor cells as putative targets for angiostatin.
Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
[TBL] [Abstract][Full Text] [Related]
8. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
10. Effect of human Angiostatin protein on human angiogenesis in vitro.
Jung SP; Siegrist B; Wang YZ; Wade MR; Anthony CT; Hornick C; Woltering EA
Angiogenesis; 2003; 6(3):233-40. PubMed ID: 15041799
[TBL] [Abstract][Full Text] [Related]
11. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.
Hanford HA; Wong CA; Kassan H; Cundiff DL; Chandel N; Underwood S; Mitchell CA; Soff GA
Cancer Res; 2003 Jul; 63(14):4275-80. PubMed ID: 12874037
[TBL] [Abstract][Full Text] [Related]
12. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity determination of human angiostatin (k1-3) in culture cells and larvae of silkworm.
Wang YF; Jin YF; Zhang YZ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):482-7. PubMed ID: 12098772
[TBL] [Abstract][Full Text] [Related]
14. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
Merchan JR; Chan B; Kale S; Schnipper LE; Sukhatme VP
J Natl Cancer Inst; 2003 Mar; 95(5):388-99. PubMed ID: 12618504
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640
[TBL] [Abstract][Full Text] [Related]
17. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation.
Chen YH; Wu HL; Li C; Huang YH; Chiang CW; Wu MP; Wu LW
Thromb Haemost; 2006 Apr; 95(4):668-77. PubMed ID: 16601838
[TBL] [Abstract][Full Text] [Related]
19. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
20. Laminin SIKVAV peptide-induced angiogenesis in vivo is potentiated by neutrophils.
Kibbey MC; Corcoran ML; Wahl LM; Kleinman HK
J Cell Physiol; 1994 Jul; 160(1):185-93. PubMed ID: 7517404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]